Aligos Therapeutics, Inc. Common Stock vs. Amgen Inc
Amgen Inc (AMGN) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| ALGS | AMGN | |
|---|---|---|
| Market Cap | $45.46 million | $224.14 billion |
| Revenue (TTM) | — | $38.09 billion |
| Net Income (TTM) | — | $8.74 billion |
AMGN leads on 1 of 1 size & scale factors.
Valuation
| ALGS | AMGN | |
|---|---|---|
| P/E Ratio | — | 25.73 |
| Price / Book | — | 19.18 |
| Price / Sales | — | 5.88 |
ALGS and AMGN split the valuation factors evenly.
Profitability
| ALGS | AMGN | |
|---|---|---|
| Net Margin | — | 22.95% |
| Return on Equity | — | 74.80% |
ALGS and AMGN split the profitability factors evenly.
Dividend
| ALGS | AMGN | |
|---|---|---|
| Dividend Yield | — | 2.43% |
| Payout Ratio | — | 62.61 |
ALGS and AMGN split the dividend factors evenly.
Risk & Sentiment
| ALGS | AMGN | |
|---|---|---|
| Short Interest | 36.27% | 1.66% |
AMGN leads on 1 of 1 risk & sentiment factors.
Dig deeper: ALGS overview, ALGS financials, AMGN overview, AMGN financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.